Nov 11 (Reuters)- Taiko Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2025 Sep 30, 2024 Dec 31, 2025 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 4.23 4.58 6.30 (-7.6 pct) (+3.7 pct) (+0.1 pct) Operating 324 mln 726 mln 300 mln (-55.3 pct) (-52.4 pct) Recurring 325 mln 705 mln 300 mln (-53.9 pct) (-56.4 pct) Net 669 mln 714 mln 580 mln (-6.3 pct) (-35.4 pct) EPS 13.33 yen 14.24 yen 11.54 yen Ann Div NIL -Q2 div NIL NIL -Q4 div NIL NOTE - Taiko Pharmaceutical Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T